These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls

Michael Brush
These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls

Sen. Elizabeth Warren’s health-care reform crusade is rattling biotech investors — but that’s not the industry’s only problem, writes Michael Brush.